SCHEMBL7055708

SCHEMBL7055708

C=C=C1CC[C@H]2[C@@H]3CCc4cc(O)ccc4[C@H]3CC[C@]12C

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 10/20 0.69
ESR2 Q92731 8/20 0.69
SHBG P04278 5/20 0.69
HSD17B10 Q99714 4/20 0.69
LMNA P02545 4/20 0.69
PGR P06401 4/20 0.69
AR P10275 4/20 0.69
SLC6A4 P31645 4/20 0.69
SLC6A3 Q01959 4/20 0.69
CYP3A4 P08684 4/20 0.69
STS P08842 3/20 0.69
SERPINA6 P08185 3/20 0.69
SNCA P37840 3/20 0.69
HIF1A Q16665 3/20 0.69
HTR2B P41595 3/20 0.69
HSD17B1 P14061 2/20 0.69
AKR1B10 O60218 2/20 0.69
CYP1A2 P05177 2/20 0.69
MAPT P10636 2/20 0.69
AKR1B1 P15121 2/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12888972 0.85 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL1236350 0.85 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL14924234 0.85 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL5525067 0.85 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL13752801 0.83 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
SCHEMBL13655771 0.83 ESR1 (0.75) ESR1ESR2SHBGHSD17B10LMNA
Estrone SCHEMBL23529835 0.82 CYP19A1 (0.95) ESR1ESR2SHBGHSD17B10LMNA
Estrone SCHEMBL12054811 0.81 CYP19A1 (1.00) ESR1ESR2SHBGHSD17B10LMNA
Estrone SCHEMBL15079288 0.81 CYP19A1 (1.00) ESR1ESR2SHBGHSD17B10LMNA
Estrone SCHEMBL157262 0.81 CYP19A1 (1.00) ESR1ESR2SHBGHSD17B10LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0830369-B1 NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN PHARM INC (US) 2003-05-14 EP disclosed
US-6331534-B1 ADMINISTERING EFFECTIVE AMOUNT OF STEROID WITHIN NASAL PASSAGE OF INDIVIDUAL SUCH THAT IT BINDS SPECIFICALLY TO RECEPTORS ON SURFACE OF NASAL NEUROEPITHELIAL CELLS IN VOMERONASAL ORGAN PHERIN PHARMACEUTICALS, INC. 2001-12-18 US disclosed
US-6242619-B1 BEHAVIORAL OR PHYSIOLOGICAL RESPONSE, REDUCTION OF NEGATIVE AFFECT, MOOD, AND CHARACTER TRAITS; NASAL ADMINISTRATION OF VOMEROPHERINS OR PHEROMONES, NERVOUS SYSTEM DRUG MODE PHERIN PHARMACEUTICALS, INC. 2001-06-05 US disclosed
US-6117860-A NASALLY ADMINISTERING STEROID WHICH BINDS TO A SPECIFIC NEUROEPITHELIAL RECEPTOR FOR ALLEVIATING PREMENSTRUAL TENSION AND ANXIETY PHERIN PHARMACEUTICALS, INC. (US) 2000-09-12 US disclosed
US-6066627-A ALTERING BLOOD CONCNETRATION OF LUTEINIZING HORMONE PHERIN CORPORATION (US) 2000-05-23 US disclosed
US-6057439-A EPOXYSTEROIDS PHERIN CORPORATION (US) 2000-05-02 US disclosed
US-5962443-A 19-nur-pregnane steroids as neurochemical initiators of change in human hypothalamic function PHERIN CORPORATION (US) 1999-10-05 US disclosed
EP-0830369-A4 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN PHARM INC (US) 1999-06-09 EP disclosed
US-5861388-A TREATMENT OF ESTROGEN DEPENDENT DISORDERS AS FOR EXAMPLEBREAST CANCER SRI INTERNATIONAL (US) 1999-01-19 US disclosed
US-5792757-A ANTIFERTILITY AGENTS, ANXIOLYTIC AGENTS PHERIN PHARMACEUTICALS (US) 1998-08-11 US disclosed
US-5763432-A TREATMENT OF ESTROGEN-DEPENDENT DISORDERS SRI INTERNATIONAL (US) 1998-06-09 US disclosed
EP-0830369-A1 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS Pherin Pharmaceuticals, Inc. (US) 1998-03-25 EP disclosed
WO-1996040727-A1 NOVEL NOR-PREGNANES FOR INDUCING HYPOTHALAMIC EFFECTS PHERIN PHARMACEUTICALS, INC. (US) 1996-12-19 WO disclosed